BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2025 Unaudited Revenue from Continuing Operations [Yahoo! Finance]
BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2025 Unaudited Revenue from Continuing Operations
BioLife Solutions (NASDAQ:BLFS) was given a new $34.00 price target on by analysts at Northland Securities.
BioLife Solutions (NASDAQ:BLFS) had its "buy" rating reaffirmed by analysts at UBS Group AG.
BioLife Solutions (NASDAQ:BLFS) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $32.00 price target on the stock.